A Germany- based HS dermatologist shares perspectives on HS diagnosis and in-depth insights into the HS treatment landscape. They discuss use and sequencing of key drug classes, the outlook for emerging therapies, and practical access and reimbursement themes.

This interview was conducted on March 11, 2026.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.